Articles

Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease

in Experimental Pharmacology and Drug Discovery

• Samuel Ruiz de Martín Esteban
• Irene Benito-Cuesta
• Itziar Terradillos
• Ana M. Martínez-Relimpio
• M. Andrea Arnanz
• Gonzalo Ruiz-Pérez
• Claudia Korn
• Catarina Raposo
• Roman C. Sarott
• Matthias V. Westphal

Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits

in Neuropharmacology

• Anthony S. Ferranti
• Daniel J. Foster

Drug-Resistant Temporal Lobe Epilepsy Alters the Expression and Functional Coupling to Gαi/o Proteins of CB1 and CB2 Receptors in the Microvasculature of the Human Brain

in Pathological Conditions

• María de los Ángeles Nuñez-Lumbreras
• José Luis Castañeda-Cabral
• María Guadalupe Valle-Dorado
• Vicente Sánchez-Valle
• Sandra Orozco-Suárez
• Rosalinda Guevara-Guzmán
• Iris Martínez-Juárez
• Mario Alonso-Vanegas
• Fruzsina Walter
• Maria A. Deli

Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders

in Neurodegeneration

• Gemma Navarro
• Paula Morales
• Carmen Rodríguez-Cueto
• Javier Fernández-Ruiz
• Nadine Jagerovic
• Rafael Franco

Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation

• Nynke J. van den Hoogen
• Erika K. Harding
• Chloé E. D. Davidson
• Tuan Trang

CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease

in Neurodegeneration

• Ester Aso
• Isidro Ferrer

Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders

in Molecular Psychiatry

• Alvaro Morcuende
• María Salud García-Gutiérrez
• Simone Tambaro
• Elena Nieto
• Jorge Manzanares
• Teresa Femenia

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1

in Neuropharmacology

• Patrizia Ratano
• Maura Palmery
• Viviana Trezza
• Patrizia Campolongo

Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease

in Neuropharmacology

• Hong Zhang
• Wei He
• Xue-Fei Hu
• Yan-Zhen Li
• Yong-Min Liu
• Wen-Qiang Ge
• Ou-Yang Zhanmu
• Chao Chen
• Yu-Ye Lan
• Yang-Shuai Su

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors

in Experimental Pharmacology and Drug Discovery

• Eva Martínez-Pinilla
• Katia Varani
• Irene Reyes-Resina
• Edgar Angelats
• Fabrizio Vincenzi
• Carlos Ferreiro-Vera
• Julen Oyarzabal
• Enric I. Canela
• José L. Lanciego
• Xavier Nadal

Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets

in Brain Disease Mechanisms

• María Gómez-Ruiz
• Carmen Rodríguez-Cueto
• Eva Luna-Piñel
• Mariluz Hernández-Gálvez
• Javier Fernández-Ruiz

Are CB2 Receptors a New Target for Schizophrenia Treatment?

in Psychopharmacology

• Isadora L. Cortez
• Naielly Rodrigues da Silva
• Francisco S. Guimarães
• Felipe V. Gomes

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

in Neuropharmacology

• Gemma Navarro
• Katia Varani
• Irene Reyes-Resina
• Verónica Sánchez de Medina
• Rafael Rivas-Santisteban
• Carolina Sánchez-Carnerero Callado
• Fabrizio Vincenzi
• Salvatore Casano
• Carlos Ferreiro-Vera
• Enric I. Canela

Spontaneous Activity of CB2 Receptors Attenuates Stress-Induced Behavioral and Neuroplastic Deficits in Male Mice

in Experimental Pharmacology and Drug Discovery

• Melissa A. Ribeiro
• Rafael P. Aguiar
• Franciele F. Scarante
• Eduardo J. Fusse
• Rubia M. W. de Oliveira
• Francisco S. Guimaraes
• Alline C Campos

Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease

in Neurodegeneration

• Hayate Javed
• Sheikh Azimullah
• M. Emdadul Haque
• Shreesh K. Ojha

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms

in Experimental Pharmacology and Drug Discovery

• Xiang-Hu He
• Ewa Galaj
• Guo-Hua Bi
• Yi He
• Briana Hempel
• Yan-Lin Wang
• Eliot L. Gardner
• Zheng-Xiong Xi